Difference between revisions of "2016 Workshop on Free Energy Methods in Drug Design: Targeting Cancer"
m |
|||
| Line 9: | Line 9: | ||
Our goal in this workshop is to bring together experts from pharma and supporting industries, as well as academia, in an intense and focused workshop to identify challenges and help chart the path forward. We are particularly interested in hearing about use cases, pitfalls and their solutions, and so on. We also firmly believe we can learn a great deal from failure, so we hope participants will go beyond just highlighting success stories to provide more detailed insight into successes and failures. | Our goal in this workshop is to bring together experts from pharma and supporting industries, as well as academia, in an intense and focused workshop to identify challenges and help chart the path forward. We are particularly interested in hearing about use cases, pitfalls and their solutions, and so on. We also firmly believe we can learn a great deal from failure, so we hope participants will go beyond just highlighting success stories to provide more detailed insight into successes and failures. | ||
| + | |||
| + | == Organizers == | ||
| + | * John Chodera, Memorial-Sloan Kettering Cancer Center (john.chodera@choderalab.org) | ||
| + | * Brian McClain, Vertex Pharmaceuticals (brian_mcclain@vrtx.com) | ||
| + | * David Mobley, University of California-Irvine (dmobley@uci.edu) | ||
| + | * Michael Schnieders, The University of Iowa (michael-schnieders@uiowa.edu) | ||
| + | * Michael Shirts, University of Virginia (michael.shirts@virginia.edu) | ||
| + | * Camilo Velex-Vega, Novartis (camilo.velez-vega@novartis.com) | ||
Revision as of 14:05, 19 October 2015
The 2016 Workshop on Free Energy Calculations in Drug Design
Dates: May 16th-18th, 2016
Venue: Auditorium of Building 1, Vertex Pharmaceuticals Headquarters, Boston, MA
50 Northern Avenue
Boston, MA 02210
Introduction
This workshop focuses on free energy techniques—the latest innovations and use cases, force field parameterization as it touches these techniques, and sampling practices, among other things. We as organizers believe that these techniques are even closer than before to making an impact in appropriate drug discovery applications, by allowing physics-based prediction of physical properties such as binding affinity, selectivity, solubility, and membrane permeability. However, a number of challenges still remain. This workshop provides a unique opportunity to assess where we are today and what challenges must be tackled next to bring the potential of free energy techniques to bear on real-world applications. We also seek to identify particular problems in drug discovery where these methods can have an impact.
Our goal in this workshop is to bring together experts from pharma and supporting industries, as well as academia, in an intense and focused workshop to identify challenges and help chart the path forward. We are particularly interested in hearing about use cases, pitfalls and their solutions, and so on. We also firmly believe we can learn a great deal from failure, so we hope participants will go beyond just highlighting success stories to provide more detailed insight into successes and failures.
Organizers
- John Chodera, Memorial-Sloan Kettering Cancer Center (john.chodera@choderalab.org)
- Brian McClain, Vertex Pharmaceuticals (brian_mcclain@vrtx.com)
- David Mobley, University of California-Irvine (dmobley@uci.edu)
- Michael Schnieders, The University of Iowa (michael-schnieders@uiowa.edu)
- Michael Shirts, University of Virginia (michael.shirts@virginia.edu)
- Camilo Velex-Vega, Novartis (camilo.velez-vega@novartis.com)